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Abstract
Background: In July 2009, French public health authorities embarked in a mass vaccination campaign against A/H1N1 2009
pandemic-influenza. We explored the attitudes and behaviors of the general population toward pandemic vaccination.
Methodology/Principal Findings: We conducted a cross-sectional online survey among 2,253 French representative adults
aged 18 to 64 from November 17 to 25, 2009 (completion rate: 93.8%). The main outcome was the acceptability of A/H1N1
vaccination as defined by previous receipt or intention to get vaccinated (‘‘Yes, certainly’’, ‘‘Yes, probably’’). Overall 17.0% (CI
95%, 15.5% to 18.7%) of respondents accepted A/H1N1 vaccination. Independent factors associated with acceptability
included: male sex (p=.0001); older age (p=.002); highest or lowest level of education (p=.016); non-clerical occupation
(p=.011); having only one child (p=.008); and having received seasonal flu vaccination in prior 3 years (p,.0001).
Acceptability was also significantly higher among pregnant women (37.9%) and other at risk groups with chronic diseases
(34.8%) (p=.002). Only 35.5% of respondents perceived A/H1N1 influenza illness as a severe disease and 12.7% had
experienced A/H1N1 cases in their close relationships with higher acceptability (p,.0001 and p=.006, respectively). In
comparison to 26.0% respondents who did not consult their primary care physician, acceptability was significantly higher
among 8.0% respondents who were formally advised to get vaccinated, and lower among 63.7% respondents who were not
advised to get vaccinated (respectively: 15.8%, 59.5% and 11.7%- p,.0001). Among respondents who refused vaccination,
71.2% expressed concerns about vaccine safety.
Conclusions/Significance: Our survey occurred one week before the peak of the pandemic in France. We found that
alarming public health messages aiming at increasing the perception of risk severity were counteracted by daily personal
experience which did not confirm the threat, while vaccine safety was a major issue. This dissonance may have been
amplified by having not involved primary care physicians in the mass vaccination campaign.
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Introduction
Following the recommendations of the World Health Organi-
zation [1], French public health authorities have decided to
embark in a mass vaccination campaign to mitigate the
transmission of the A/H1N1 2009 pandemic-influenza. In July
2009, the French government bought a total of 94 million doses of
vaccines with the explicit goal to provide two successive vaccine
doses to 75% of the whole population (62.5 million inhabitants in
metropolitan France). Such a goal was quite ambitious as
compared to usual rates of seasonal flu vaccine uptake in the
population: 50% in targeted subgroups at risk for influenza
complications; and less than 25% otherwise [2,3]. Another key
decision of French authorities was to implement the A/H1N1
immunization campaign in mass vaccination centers, especially
put in place on this occasion, in contrast to the usual prescription
and administration of seasonal flu vaccines by general practitioners
and other groups of ambulatory specialist physicians (mainly,
pediatricians and gynecologists). In particular, primary care
physicians were not associated with the A/H1N1 immunization
campaign for economic and logistical reasons [4].
On October 20, 2009, the distribution of available vaccine
supply started in hospitals for 1.2 million health care professionals
including doctors and nurses of primary care settings [5]. On
November 12, the access to vaccines was extended in mass
vaccination centers for: 1.7 million household contacts and
caregivers for children younger than 6 months of age; 880,000
additional health care professionals in primary care settings; and
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H1N1 influenza complications (including pregnant women and
individuals with chronic pulmonary disease, chronic heart disease
or diabetes identified as ‘‘priority groups’’ by the Advisory Public
Health Council) [5]. On December 1, the vaccination campaign
was extended to other at-risk individuals older than 65 years, while
vaccination began in schools. All targeted individuals were
identified by the French Sickness Insurance Fund (Social Security),
and received a personalized invitation letter from the Minister of
Health that was necessary to access the closest vaccination center.
It is a well-established fact that risk perceptions influence
influenza vaccine uptake [6,7], and that there is a need to consider
and understand factors underlying people’s decision about vacci-
nation to create an effective immunization program [8,9,10]. The
French National Research Institute for Microbiology and Infectious
Diseases (IMMI), that is part of the French National Institutes of
Health (INSERM and the other involved health research agencies),
has therefore established, through the Web, a representative panel
of the French population aged 18 to 64 years in order to follow the
evolution of attitudes and behaviors toward the mass vaccination
campaign. The first cross-sectional survey was carried out in the
panel from November 17 to 25, 2009, to assess the acceptability of
A/H1N1 pandemic vaccination in the French general population,
as well as its main determinants including risk perception, at the
initiation of the campaign. Since seasonal flu immunization
behaviors in the general population have been shown to be
associated with behaviors, attitudes, and advice from primary care
physicians [2,11,12,13], we also assessed whether the choice not to
mobilize primary care physicians may negatively affect compliance
with the mass vaccination campaign.
Methods
Ethics statement
The survey was approved by the National Data Protection
Authority (Commission Nationale Informatique et Liberte ´s/
CNIL) which is in charge of ethical issues and protection of
individual data collection in France, and written informed consent
was obtained from each participant.
Sampling procedure
A sample was randomly selected from an online research panel
of more than 220,000 nationally representative households of the
French general population developed and maintained by IPSOS
Interactive Services (Gentilly, France), a survey research firm
(http://www.ipsos-interactive.com/). The sample size of 2,200
was calculated to obtain a maximum margin of sampling error of
62.0 percentage points for an overall acceptability of A/H1N1
vaccination of 50%. A total of 19,780 households were randomly
drawn to reach the sample size within a week. Prior information
on the panelists was used to determine eligibility and to draw a
stratified random sample with oversampling of panelists with low
response rates. To be eligible, panelists had to be aged 18 to 64
years and having not answered a survey on communicable diseases
in the last twelve weeks or more than 6 surveys in the last four
weeks. To limit coverage bias, random sampling was stratified to
match French official census statistics for gender; age (18–24; 25–
34; 35–44; 45–54; 55–64); occupation (5 categories); household
size (1; 2; 3; 4; 5 members or more), population in the area of
residence (less than 20,000; 20,000 to 100,000; 100,000 to
200,000; 200,000 inhabitants or more); and region (Ile-de-France
including Paris; North-East; North-West; South-East; South-
West). To limit selection bias, panelists with low response rates
were oversampled relative to others, e.g. fifty panelists with a 1%
chance to take the survey were randomly drawn for one panelist
with a 50% chance. In addition, panelists were invited by email to
participate to an ‘‘academic survey’’ dealing ‘‘with protective
behaviors against communicable diseases’’. This initial invitation
did not refer explicitly to the influenza-pandemic and did not
mention specifically the words ‘‘vaccination’’, ‘‘swine flu’’, or
‘‘pandemic’’. Finally, 2,093 (12.0%) panelists had completed the
survey out of the 17,425 invitations mailed out on November 17,
and an additional 2,355 households oversampling young single
males were invited on November 23 to achieve a French
representative sample.
Survey instrument
The online questionnaire used an adaptative questioning to
reduce the number of questions with one question per screen [14].
The online questionnaire is available in French language at
http://www.enquetegrippeH1N1.org with an English translation
at http://www.H1N1flusurvey.org. Nine questions dealt with the
socio-demographic characteristics of the respondent. Two ques-
tions, validated in previous French national health surveys [15],
assessed individual’s subjective health state using a 5-point scale
(from ‘‘poor’’ to ‘‘excellent’’), and consultations with physicians in
the prior six months. In addition, respondents were asked if they
were pregnant, if they had a chronic disease, and what was their
level of compliance with seasonal flu vaccination and other
vaccinations recommended by their primary care physician (for
example, before travelling abroad).
Respondents were then asked if they had an episode of flu since
May 2009, and two questions allowed to determine the extent to
which these episodes could be related to the A/H1N1 2009
influenza virus (as confirmed by a lab test in ambulatory medicine
or by a hospitalization). Three additional questions asked whether
respondents know personally someone who contracted A/H1N1
flu (family members, work colleagues, neighborhood and commu-
nity).
Behaviors and attitudes toward A/H1N1 vaccination were
assessed using three successive questions. First, respondents were
asked if they had already been vaccinated (yes/no). All those who
had not been vaccinated were subsequently asked if they were
willing to get vaccinated using a 4-point scale (‘‘Yes, certainly’’,
‘‘Yes, probably’’, ‘‘No, probably not’’, ‘‘No, certainly not’’).
Finally, the main reasons for getting vaccinated or not were asked
with two alternative multiple choices questions [16].
Four questions dealt with respondents’ risk perceptions of the
threat associated with the A/H1N1 influenza-pandemic: two
questions asked respondents whether they were ‘‘not at all
worried’’, ‘‘somewhat worried’’, ‘‘worried’’ or ‘‘very worried’’
about the A/H1N1 influenza-pandemic for themselves or their
close relatives; another question asked if the respondent personally
felt at ‘‘higher risk’’, ‘‘same risk’’, ‘‘lower risk than average’’ or
‘‘not at all at risk’’ to contract A/H1N1 influenza infection; finally,
respondents were asked if they estimated that A/H1N1 influenza-
pandemic illness should be considered a ‘‘severe disease’’ (‘‘not at
all severe’’, ‘‘somewhat severe’’, ‘‘severe’’, ‘‘very severe’’).
Order response bias from subjective assessment was controlled
by random allocation of: the direction of all ordinal scales like the
ones just mentioned; and the two sections of questions addressing
attitudes and behaviors on the one hand, and risk perceptions on
the other hand. In addition, participants had unlimited time to
complete the survey.
Finally, we used external data collected regularly on the
panelists and made available for the present analysis by courtesy
of IPSOS Interactive Services. IPSOS panel data were used to
cross-validate the 6 stratification variables as well as self-declared
Pandemic Vaccination in France
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diseases.
Statistical analysis
The main outcome was the acceptability of A/H1N1 vaccination
as defined by previous receipt or intention to get vaccinated (‘‘Yes,
certainly’’, ‘‘Yes, probably’’) versus unwillingness to get vaccinated
(‘‘No, probably not’’, ‘‘No, certainly not’’). Univariate analyses were
carried out using chi-square tests. For ordinal variables, the
Cochran-Armitage test for trend was performed. Multivariate
logistic regression was carried out with acceptability of A/H1N1
vaccination as the dependent variable. All variables significant at
p,.15 in univariate analyses were introduced in the initial
multivariate model. If several variables were strongly linked, then
all could be considered as ‘‘proxies’’ of the same phenomenon (i.e.
risk perception, level of compliance with vaccination), and a single
variable was selected to avoid problems of multicollinearity. All
covariates were selected using a backward selection (p,.05 to stay).
However, sample stratification variables (gender, age, occupation,
household size, population in the area of location and region) were
forced in the final model even if they did not meet the p,.05
criterion. Finally, we looked for additional two-way interaction
effects using a backward selection (p,.05 to stay) on the final model
augmented with all two-way interaction effects. All analyses were
based on two-sided p values, with p,.05 considered to indicate
statistical significance. All analyses were carried out using SAS 9.1.3
statistical software (SAS Institute, Cary, NC).
Results
A total of 2,253 adults aged 18 to 64 completed the online survey
betweenNovember17 and 25,2009 (completionrate =93.8%). No
differences for the six socio-demographic and geographic variables
used for stratification were found between respondents and the
French general population as observed in the latest census statistics
[17]. Eighty-six (3.8%) respondents declared that they had an
episode of flu in the prior three months and were excluded from the
present analysis, although 61 (71%) of these respondents did not
receive a formal diagnosis of an infection by A/H1N1 2009
influenza virus.
Overall, the acceptability of A/H1N1 vaccination was 17.0%
(CI 95%, 15.5% to 18.7%). Only a minority (1.9% -n=42) had
already received the A/H1N1 pandemic vaccine (Table 1). This
proportion was higher (10.9% -n=13) among health care
professionals in accordance with the timing of the vaccination
campaign. An additional number of 327 respondents (15.1% in
total sample, 9.2% among health care professionals) declared that
they had the intention to get vaccinated. The most frequent
quoted reason to accept vaccination was ‘‘self-protection’’ (74.5%),
while only one quarter (24.1%) invoked that getting vaccinated
was ‘‘a civic duty’’ (Table 2). Among 1,798 respondents who did
not accept vaccination, the main reasons were concerns about
vaccine safety and fear of vaccine side effects (respectively quoted
by 71.2% and 68.4%).
Acceptability of A/H1N1 vaccination was significantly higher
among pregnant women (37.9% -p=.003) and other at risk
individuals with chronic diseases (34.8% -p,.001) as confirmed in
multivariate analysis (Table 1). Acceptability of A/H1N1 vaccination
was slightly higher among health care professionals (20.2%), but this
difference was not statistically significant even in univariate analysis
(p=.35). Among parents with children in the household (n=1,030),
225 (21.8%) respondents werewilling to get their children vaccinated;
about a quarter (25.8%) of parents who accepted vaccination for their
children did not accept vaccination for themselves. On the contrary,
only 30 (3.7%) out of 805 parents who refused vaccination for their
children did accept vaccination for themselves.
Table 1 also shows that acceptability of vaccination was
significantly related to a number of socio-demographic characteris-
tics, even after multivariate adjustment. Female respondents were less
willing to get vaccinated than males (p=.0001). Acceptability of
vaccination was significantly lower for adults less than 35 (p=.002)
and increased with age (Cochran-Armitage test for trend: p,.0001).
Respondents who graduated from high school or undergraduate
studies at university were less willing to get vaccinated than others
(p=.016). Clerks were less willing to get vaccinated than respondents
with another social grade (p=.011). The presence of onlyone childin
the household was associated with a higher acceptability when
compared with both households with no child and those who had
more than one child (p=.008). Acceptability of A/H1N1 vaccination
was similar in all French regions but lower among respondents living
in small towns with 20,000 to 100,000 inhabitants (p=.044).
At time of the survey, the majority of the French general
population did not associate A/H1N1 influenza-pandemic with a
serious threat. Only one third of respondents (35.5%) considered
A/H1N1 influenza-pandemic illness as a ‘‘severe’’ or ‘‘very
severe’’ disease (Table 1), and even less respondents declared that
they were ‘‘worried’’ or ‘‘very worried’’ about the A/H1N1
influenza-pandemic for themselves, and that they personally felt at
‘‘higher risk than average’’ for contracting A/H1N1 influenza
infection (15.1% and 8.2%, respectively). Respondents belonging
to at-risk groups (including pregnant women) were more likely to
be worried for themselves (23.9%) than others (14.4% -p,.01); in
contrast, health care professionals were not more likely to be
worried for themselves (15.1%) than others. A higher proportion of
respondents (29.2%) expressed concerns (being ‘‘worried’’ or ‘‘very
worried’’) about the risk that one family member may contract A/
H1N1 influenza infection, and this proportion was significantly
higher among parents with children in the household (35.0%
versus 23.8% in the rest of the sample -p,.001).
Respondents with a higher perception of the severity of
influenza-pandemic illness were significantly more likely to accept
vaccination, and this was confirmed after multivariate adjustment
(Table 1; p,.0001). When alternative constructs of risk percep-
tions were introduced in the multivariate analysis, they also remain
significant in each of the final models (p,.0001): being ‘‘worried’’
or ‘‘very worried’’ about the A/H1N1 influenza-pandemic for
oneself (OR=2.90; 95% CI: 2.12 to 3.97) or one’s close relatives
(OR=3.38; 95% CI: 2.58 to 4.42); feeling personally at ‘‘higher
risk than average’’ to contract A/H1N1 influenza infection
(OR=2.63; 95% CI: 1.75 to 3.85).
Respondents who had already been confronted to a case of A/
H1N1 influenza-pandemic illness in their close relationships
(family members and/or work colleagues) were more likely to
accept A/H1N1 vaccination (Table 1; p=.006). It should be
noted that acceptability of vaccination was lower among those who
knew individuals who had contracted A/H1N1 influenza but not
in their close relationships than among those who did not know
any flu case (although this difference was not significant after
multivariate adjustment).
Respondents who were vaccinated for seasonal influenza at least
once in the prior three years were also more likely to accept A/
H1N1 vaccination (Table 1; p,.0001). Similarly, less than half of
respondents (46.1%) declared that they were always ‘‘compliant’’
with vaccinations recommended by their primary care physician,
and acceptability of A/H1N1 pandemic vaccination was higher
among them (25.9%) as compared to others (9.4%) (p,.0001).
When introduced in the multivariate analysis instead of seasonal
influenza immunization behavior, the level of compliance with
Pandemic Vaccination in France
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survey, November 17 to 25, 2009, N=2,167).
Acceptance of A/H1N1 pandemic vaccination, N (%)
Total
respondents
(N=2,167)
Univariate
comparison
(1)+(2) vs. (3)
Multivariate
logistic model
Yes, N=369 (17.0%)
No, N=1,798
(83.0%) (1)+(2) vs. (3)
(1) Already
vaccinated,
N=42 (1.9%)
(2) Intention to
get vaccinated,
N=327 (15.1%)
(3) No intention
to get vaccinated p-value{
Adjusted OR
[CI 95%]{ p-value{
Sex # ,.0001 .0001
Male 29 (2.6) 201 (18.3) 872 (79.1) 1,102 (50.9) Ref.
Female 13 (1.2) 126 (11.8) 926 (87.0) 1,065 (49.1) 0.57 [0.43; 0.76]
Age # ,.0001 .002
18-34 10 (1.2) 96 (11.5) 728 (87.3) 834 (38.5) Ref.
35-54 19 (1.9) 163 (16.3) 820 (81.8) 1,002 (46.2) 1.41 [1.03; 1.93]
$55 13 (3.9) 68 (20.6) 250 (75.5) 331 (15.3) 2.11 [1.38; 3.24]
Education# .001 .016
University graduates 8 (3.5) 50 (21.8) 171 (74.7) 229 (10.6) Ref.
High school graduates or
college undergraduates
19 (1.5) 163 (12.8) 1,094 (85.7) 1,276 (58.9) 0.53 [0.34; 0.82]
Some high school 14 (2.4) 100 (16.8) 480 (80.8) 594 (27.4) 0.69 [0.42; 1.13]
Primary level of education 1 (1.5 ) 14 (20.6) 53 (77.9) 68 (3.1) 0.87 [0.40; 1.92]
Social Grade # .005 .011
Clerical 12 (2.0) 62 (10.4) 521 (87.6) 595 (27.5) Ref.
Managerial 5 (1.8) 56 (20.1) 218 (78.1) 279 (12.9) 2.14 [1.34; 3.41]
Manual 7 (1.3) 85 (16.2) 434 (82.5) 526 (24.3) 1.60 [1.07; 2.37]
Self Employed 1 (0.8) 22 (19.0) 93 (80.2) 116 (5.3) 2.18 [1.19; 3.99]
Retired / Unemployed 17 (2.6) 102 (15.7) 532 (81.7) 651 (30.0) 1.49 [1.01; 2.20]
Number of adults
in household #
.84 .85
One 10 (1.7) 85 (14.6) 489 (83.7) 584 (26.9) Ref.
Two 23 (2.0) 174 (15.3) 938 (82.7) 1,135 (52.4) 1.00 [0.72; 1.37]
More than two 9 (2.0) 68 (15.2) 371 (82.8) 448 (20.7) 1.10[0.74; 1.63]
Number of children in
household#
.008 .008
None 20 (1.7) 152 (13.4) 965 (84.9) 1,137 (52.5) Ref.
One 15 (3.2) 85 (18.3) 364 (78.5) 464 (21.4) 1.68 [1.21; 2.35]
More than one 7 (1.2) 90 (15.9) 469 (82.9) 566 (26.1) 1.36 [0.96; 1.91]
Town size # .12 .044
, 20,000 inhabitants 14 (1.6) 141 (16.0) 726 (82.4) 881 (40.7) Ref.
[20,000 ; 100,000[ inhabitants 4 (1.4) 36 (12.6) 246 (86.0) 286 (13.2) 0.61 [0.40; 0.95]
[100,000 ; 200,000[ inhabitants 6 (4.8) 23 (18.6) 95 (76.6) 124 (5.7) 1.46 [0.86; 2.50]
$ 200,000 inhabitants 18 (2.1) 127 (14.5) 731 (83.4) 876 (40.4) 0.92 [0.68; 1.24]
Region # .35 .18
Ile de France (includes Paris) 7 (1.7) 55 (13.2) 354 (85.1) 416 (19.2) Ref.
North-West 14 (2.9) 81 (16.6) 393 (80.5) 488 (22.5) 1.57 [1.03; 2.39]
North-East 7 (1.4) 75 (14.4) 438 (84.2) 520 (24.0) 1.09 [0.72; 1.67]
South-West 2 (0.9) 34 (15.3) 186 (83.8) 222 (10.3) 0.99 [0.58; 1.70]
South-East 12 (2.3) 82 (15.7) 427 (82.0) 521 (24.0) 1.18 [0.78; 1.80]
Seasonal flu vaccination
in the prior 3 years
,.0001 ,.0001
Never 10 (0.6) 188 (11.1) 1,500 (88.3) 1,698 (78.4) Ref.
Yes, at least once 32 (6.8) 139 (29.6) 298 (63.6) 469 (21.6) 3.21 [2.40; 4.29]
Pandemic Vaccination in France
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95% CI: 2.39 to 4.15).
Nearly three quarters of the population (74.0%) had consulted a
physician at least once in the prior 6 months (Table 1).Among these
1,604 respondents, 173 (8.0% of total sample) were formally advised
by their primary care physician to get vaccinated, and 51 (2.3% of
total sample) were advised to do so by another health care
professional. About half (57/103) respondents being advised to get
vaccinated by their primary care physician and accepting A/H1N1
vaccination declared that their physician’s advice was their main
motivation to do so. Among 167 respondents at risk for A/H1N1
influenza complications, 88.6% had at least one medical consulta-
tion in the prior six months, but only 25.0% were formally advised
to get vaccinated. For 1,380 respondents (63.7% of total sample)
who had at least one medical consultation, no physician took this
opportunity to advise them to get A/H1N1 vaccination, while 232
respondents (10.7% of total sample) declared explicitly that A/
H1N1 vaccination was discussed during the consultation and they
were formally advised not to get vaccinated. Multivariate analysis
confirmed that those who were not advised to get vaccinated by a
health care professional were less likely to accept vaccination than
those who did not have any medical consultation in the prior six
Acceptance of A/H1N1 pandemic vaccination, N (%)
Total
respondents
(N=2,167)
Univariate
comparison
(1)+(2) vs. (3)
Multivariate
logistic model
Yes, N=369 (17.0%)
No, N=1,798
(83.0%) (1)+(2) vs. (3)
(1) Already
vaccinated,
N=42 (1.9%)
(2) Intention to
get vaccinated,
N=327 (15.1%)
(3) No intention
to get vaccinated p-value{
Adjusted OR
[CI 95%]{ p-value{
Personnally knows someone
who contracted A/H1N1 flu
.002 .006
No 27 (1.7) 238 (15.2) 1,302 (83.1) 1,567 (72.3) Ref.
Yes, in close environment
(family, working colleagues)
13 (4.7) 51 (18.6) 210 (76.7) 274 (12.7) 1.65 [1.13; 2.41]
Yes, outside close environment 2 (0.6) 38 (11.7) 286 (87.7) 326 (15.0) 0.75 [0.49; 1.13]
Belongs to priority groups
for A/H1N1 vaccination
,.0001 .002
No 23 (1.2) 263 (14.0) 1,595 (84.8) 1,881 (86.8) Ref.
Health care professionnal 13 (10.9) 11 (9.3) 95 (79.8) 119 (5.5) 0.86 [0.48; 1.52]
Pregnant women 0 0 11 (37.9) 18 (62.1) 29 (1.3) 5.09 [1.86; 13.92]
Other at-risk individuals with
chronic diseases*
6 (4.4) 42 (30.4) 90 (65.2) 138 (6.4) 1.66 [1.05; 2.62]
Medical advice about
A/H1N1 vaccination
in the prior 6 months
,.0001 ,.0001
Did not have any medical
consultation
5 (0.9) 84 (14.9) 474 (84.2) 563 (26.0) Ref.
Positive advice by a primary
care physician
22 (12.7) 81 (46.8) 70 (40.5) 173 (8.0) 4.57 [2.92; 7.14]
Positive advice by another
health care professional
4 (7.8) 11 (21.6) 36 (70.6) 51 (2.3) 1.99 [0.94; 4.18]
No positive advice by
a health care professionnal
11 (0.8) 151 (10.9) 1,218 (88.3) 1,380 (63.7) 0.57 [0.42; 0.79]
Perception of severity
of A/H1N1 influenza
illness if infected
,.0001 ,.0001
Not at all severe or
somewhat severe
14 (1.0) 129 (9.2) 1,254 (89.8) 1,397 (64.5) Ref.
Severe or very severe 28 (3.6) 198 (25.7) 544 (70.7) 770 (35.5) 3.61 [2.76; 4.71]
Self-perception of
health state
,.0001 NS
Poor or fair 11 (2.9) 78 (21.1) 281 (76.0) 370 (17.1)
Good or very good or excellent 31 (1.7) 249 (13.9) 1,517 (84.4) 1,797 (82.9)
*60 with asthma (43%); 19 with chronic bronchitis (14.7%); 46 with diabetes (33.3%); 13 with cardiac condition (9.4%).
{chi
2 test p-values (Cochran-Armitage test for age).
{p-values for type III tests. Hosmer-Lemeshow test (p=0.46) and deviance (p=1.00) suggest that the goodness of fit was adequate for the final multivariate logistic model.
#covariates forced into multivariate model.
NS: Non significant after backward selection process, OR not provided.
doi:10.1371/journal.pone.0010199.t001
Table 1. Cont.
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advice from a primary care physician significantly increased
acceptability of vaccination; however, this was not confirmed in
the case of a positive advice by other health care professionals.
Although the deviance of the final model suggested that main
effects fit very well the data (deviance=1,481 with DF=2,106;
p=1.00), we looked for additional two-way interaction effects using
a backward selection. Two interactions effects were retained that
contrasted acceptability of A/H1N1 pandemic vaccination for risk
perception and seasonal influenza immunization depending on the
number of children in the household: 1) respondents who
considered A/H1N1 influenza-pandemic illness as a ‘‘severe’’ or
‘‘very severe’’ disease had adjusted odds-ratios for acceptability of
vaccination of 2.56 (CI 95%, 1.74 to 3.76) for those having no child;
3.74 (CI 95%, 2.21 to 6.32) for those having one child; and 6.59 (CI
95%, 3.84 to 11.32) for those having more than one child (p=.020);
and 2) respondents who were vaccinated for seasonal influenza at
least once in the prior three years had adjusted odds-ratios for
acceptability of vaccination of 4.67 (CI 95%, 3.25 to 6.99) for those
having no child; 2.85 (CI 95%, 1.61 to 5.04) for those having one
child; and 1.69 (CI 95%, 0.93 to 3.06) for those having more than
one child (p=.016). The main effects of the final model remained
significant when the two interaction effects were added with
exception of the number of children in the household (p=.15).
Discussion
This cross-sectional survey took place from November 17 to 25,
2009, shortly after the mass vaccination campaign had started in the
general population (November 12), i.e. twelve weeks after the
influenza-pandemic occurred in France and a week before the peak
(November 23–29 – Week 48) as surveillance epidemiological data
revealed subsequently [18]. Overall, the acceptability of A/H1N1
vaccination was low at 17.0% (CI 95%, 15.5% to 18.7%) among
2,167 respondents representative of the French adult population
aged18to64.ThemajorityoftheFrenchgeneralpopulationdidnot
associate A/H1N1 influenza-pandemic illness with a serious threat.
Only 35.5% of respondents perceived A/H1N1 influenza illness as a
severe disease and 12.7% had experienced A/H1N1 cases in their
close relationships with higher acceptability of vaccination (p,.0001
and p=.006, respectively). In comparison to 26.0% respondents
who did not consult their primary care physician in the prior six
months, acceptability was significantly higher among 8.0% respon-
dents who were formally advised to get vaccinated by their primary
care physician, and lower among 63.7% respondents who were not
advised to get vaccinated (respectively: 15.8%, 59.5% and 11.7%-
p,.0001). Among 1,798 respondents who refused vaccination,
71.2% expressed concerns about vaccine safety.
We found that risk perceptions of the A/H1N1 influenza-
pandemic were strongly correlated to the acceptability of
vaccination in the general population. It confirms findings from
previous surveys conducted worldwide about attitudes and
behaviors toward vaccination against seasonal flu [2,16], the
highly pathogenic A/H5N1 influenza virus [19,20,21,22], and
more recently the A/H1N1 influenza-pandemic [23,24,25,26].
However, the majority of the French general population did not
associate A/H1N1 influenza-pandemic with a serious threat, albeit
a week before the pandemic peak [18].
The substantial impact of other determinants illustrates that
while the perceived severity of the A/H1N1 influenza-pandemic
Table 2. Reasons for acceptability or not of A/H1N1 pandemic vaccination in the French adult population (online survey,
November 17 to 25, 2009, N=2,167).
Main reason(s) for acceptability of pandemic vaccination (n=369) % [CI 95%]
Protecting myself to avoid sickness 74.5 [69.8; 78.9]
Protecting my close relatives 68.8 [63.8; 73.5]
Getting vaccinated is convenient and quick 27.4 [22.9; 32.2]
A health professional advised me to get vaccinated 25.2 [20.9; 30.0]
Getting vaccinated is a civic duty 24.1 [19.8; 28.8]
Vaccination is recommended by public authorities 23.6 [19.3; 28.3]
Vaccination is free 21.1 [17.1; 25.7]
Protecting myself to avoid work absenteeism 20.1 [16.1;24.5]
Vaccines are safe 9.2 [6.5; 12.6]
Vaccines have no side effects 7.1 [4.7; 10.2]
Main reason(s) for non-acceptability of pandemic vaccination (n=1,798)
Vaccines are not safe enough 71.2 [69.0; 73.3]
Vaccines have side effects 68.4 [66.2; 70.1]
Flu is not a severe disease 19.7 [17.9; 21.7]
Vaccines lack efficacy 17.3 [15.6; 19.1]
A health professional advised me to avoid vaccination 15.3 [13.7; 17.0]
I never get the flu 15.0 [13.3; 16.7]
I dislike the shots 7.0 [5.8; 8.2]
Getting vaccinated is inconvenient and too long 3.6 [2.8; 4.6]
I have medical reasons to avoid H1N1 vaccine 1.4 [0.9; 2.1]
*Any items could be selected and thus proportions do not add to 100%. Items were presented in a random order.
doi:10.1371/journal.pone.0010199.t002
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vaccination campaign, it is not a necessary one. We found that
individual characteristics including male gender, older age, and
previous receipt of seasonal influenza vaccine were independent
predictors of the acceptability of A/H1N1 pandemic vaccination.
The same individual characteristics were similarly associated with
the acceptability of A/H1N1 pandemic vaccination in other
countries [23,24,25,26], but also with seasonal vaccine uptake in
the whole French at-risk population aged less than 65 [3]. These
findings suggest that prior beliefs and attitudes toward seasonal
influenza vaccination are major leverages to increase the uptakes
of influenza-pandemic vaccination in the general population.
However, we found that acceptability of A/H1N1 pandemic
vaccination was as low as 17.0% among the French adult
population, and concerns about A/H1N1 pandemic vaccine safety
were the main reason quoted by 71.2% respondents who denied
being vaccinated. In a Canadian qualitative study among health
care professionals and the general public, the authors found that
individuals were hesitant to accept pandemic vaccines and that
‘‘concerns about using new vaccines during a pandemic differ from
concerns about using established products in non-crisis situations’’
[9]. For an emerging public health threat that diffuses very quickly,
as it has been the case for the A/H1N1 influenza-pandemic,
perceptions of the benefits and risks of vaccinationmay continuously
evolve.Our results primarily suggest that the general population was
not reassured that A/H1N1 pandemic vaccines were safe. It calls
into question the information received by the general population at
time of the survey, and what factors may have worsened the
perception that A/H1N1 pandemic vaccines are unsafe.
At time of the survey, the A/H1N1 influenza-pandemic had
attracted massive media coverage in France, albeit in two opposite
directions. On the one hand, the severity of A/H1N1 2009
influenza illness was stressed by daily reports of fatalities in the
news media (i.e. 357 hospitalizations in intensive care units (ICUs)
and 68 deaths at time of the survey) [27], frequent messages from
public health authorities, and personal appearances in the media
of the Ministry of Health and the Head of State in order to
motivate people’s compliance with the mass vaccination cam-
paign. On the other hand, the safety of A/H1N1 pandemic
vaccines was scrutinized by the media with regard to the risk of
Guillain-Barre ´ syndrome, the limited knowledge about adjuvanted
vaccines accounting for almost all doses available in France, the
accelerated authorization procedure to market pandemic vaccines
and the actual motivations of pharmaceutical firms, while the
unclear number of vaccine injections called their protective
efficacy into question.
Although the public’s perception of a health risk usually
increases with its coverage in the news media [28], this general
trend may indeed be counteracted if this media information is
dissonant [29], and if daily personal experience does not confirm
the threat [30]. Previous population surveys in the US[31] and the
UK[32] have emphasized that after an initially high level of risk
perception, levels of anxiety waned along with the perception of
the A/H1N1 influenza-pandemic as an immediate threat and that
tackling the perception that the outbreak has been ‘‘over-hyped’’
may be difficult. In our study, 12.7% respondents reported a case
of A/H1N1 flu in their close environment. The fact that these
respondents had a significantly higher acceptability of A/H1N1
pandemic vaccination suggests that they saw the A/H1N1
influenza-pandemic as a real threat in concordance with messages
from public health authorities. On the contrary, dissonance may
have grown in the vast majority of the general population who had
no (72.3%) or indirect (15.0%) experience with A/H1N1
influenza-pandemic.
As a consequence, 74% respondents looked for medical advice
about A/H1N1 pandemic vaccination, an estimate above the
expected number of consultations for a similar period [15].
Previous studies have shown that behaviors, attitudes, and advice
from primary care physicians were strongly associated with their
patients’ immunization behavior for seasonal influenza
[2,11,12,13] as well as the ‘‘swine flu’’ in the 1976 mass
vaccination campaign in the U.S. [33]. We found consistently
that a positive advice from a primary care physician was a major
determinant of the acceptability of A/H1N1 pandemic vaccina-
tion. However, 63.7% respondents were not advised to get
vaccinated with significantly lower acceptability of A/H1N1
pandemic vaccination. First and foremost, this finding is in
accordance with the low uptake rate (10.9%) reported at time of
the survey for health care professionals who were the first priority
group to access pandemic vaccines [5,34]. To the extent that 62%
of general practitioners were willing to get vaccinated during the
summer of 2009 [35], future studies should explore whether their
behaviors and attitudes toward A/H1N1 pandemic vaccines did
evolve negatively as a result of risk communication of public health
authorities and/or their dismissal from the mass vaccination
campaign decided on August 21, 2009 [4]. Assumingly, the
decision to strictly administer A/H1N1 pandemic vaccines in ad
hoc vaccination centers had further increased dissonance in the
general population since it was in sharp contrast with the past
experience of the general population learnt from seasonal flu
vaccination that is mainly prescribed and administered by primary
care physicians in France [3], as well as policies adopted by
neighboring countries, like Belgium, Germany, and the UK [36].
Finally, we found that parents had a higher acceptability of A/
H1N1 pandemic vaccination for themselves than other adults
without children. Further analysis showed that such higher
acceptability was mediated by the perception of A/H1N1
influenza-pandemic illness as a ‘‘severe’’ or ‘‘very severe’’ disease
with an increased acceptability depending on the number of
children in the household. However, parents who denied
vaccination for themselves expressed significantly more concerns
about vaccine safety than other adults without children (76.5% vs.
66.6%, respectively; p,.0001). Quite logically, parents were
reluctant to get their children vaccinated; only a quarter of
parents accepted vaccination for their children but not for
themselves. Future studies should address more specifically
knowledge, attitudes and behaviors of parents about pandemic
vaccination of their children since children are the most important
drivers of influenza infection and may be targeted for pandemic
vaccination before their parents [5].
Our study is subject to a number of weaknesses. The advantage
of our Web-based sampling strategy is the ability to quickly deploy
a survey and thereby track responses in near real-time knowing
that risk perceptions and attitudes toward pandemic vaccination
may continuously evolve [23,31]. The possible disadvantage of this
strategy is a sacrifice of population representativeness. A non-
coverage bias is limited by the quite high Internet coverage in the
French adult population (estimated at 67% in 2008), while
coverage rates are the highest in our target population of adults
aged 18 to 64 [37]. The representativeness of online data
collection is also established to the extent that it follows the
procedure used in this survey, i.e. stratified random sampling in a
pre-existing large representative panel of the whole population
[38,39].
Although we cannot unequivocally rule out the existence of
selection bias in our online sample, our analyses are consistent with
the view that our sample is representative of the French adult
population aged 18 to 64 as compared to previous surveys
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data collection (face to face or phone interviews): 1) random
sampling in our survey was stratified to match French official
census statistics for gender, age, occupation, household size, size of
the population in the area of residence, and region [17]; 2) 22% of
respondents received seasonal influenza vaccination at least once
in the prior three years consistent with national uptake rates
around 22–24% over recent years [2]; and 3) usual explanatory
factors for seasonal flu uptake were also consistently found to
associate with acceptability of A/H1N1 vaccination (i.e. male
gender, older age, previous vaccination against seasonal flu, groups
at risk for influenza complications) [2,3].
Although such online survey shares with other survey methods
the general limitations of results based on respondent’s self-
declarations, it is well established that self-administered question-
naires tend to yield fewer reports in the socially desirable direction
than do interviewer-administered questionnaires, and a recent
study suggested that online surveys may have the lowest social
desirability bias [40]. In particular, the validity of our results was
further supported by actual immunization behaviors reported in
official statistics: the low uptake of A/H1N1 vaccine among health
care professionals (10.7%; CI 95%: 5.8% to 17.7%), who were the
first priority group to access vaccines on October 20, 2009, was
similar to the actual uptake rate (10.9%) reported at time of the
survey [34]; the low acceptability of A/H1N1 vaccination in the
French general population (17.0%; CI 95%, 15.5% to 18.7%)
predicted the low coverage rate (2.7 million people, i.e. 7.1%
coverage in the population aged 18 to 60) reported on February
28, 2010 [41].
The uptake of A/H1N1 pandemic vaccines appears to be very
low in France as compared to some other European Union and
North American countries that have undertaken a mass vaccina-
tion campaign [42,43]. While risk perceptions of A/H1N1
influenza-pandemic were expectedly found to drive immunization
behaviors, the majority of the adult population expressed concerns
about pandemic vaccines’ safety and refused vaccination for
themselves and their children. As evidence by this study and
others, risk communication of public health authorities should
primarily focus on reassuring the general population that
pandemic vaccines are safe [41]. In addition, our study shows
that the implementation of a mass vaccination campaign and the
particular role given to primary care physicians were major factors
to achieve a successful pandemic vaccination campaign. On
January 11, 2010, the French Ministry of Health reversed its
policy and authorized primary care physicians to administer A/
H1N1 vaccines. While such policy change should contribute to
increase significantly uptake rates among priority groups at risk for
A/H1N1 influenza-pandemic complications, it may have occurred
too late to change uptake rates in the general population at a time
the fist wave of the influenza-pandemic ended [44].
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